— DexCom, Inc. (NASDAQ: DXCM) reported its fourth-quarter 2019 adjusted earnings of $1.15 per share versus $0.74 per share expected.
— Total revenue grew by 37% to $462.8 million versus $442.38 million expected. This is driven by volume growth, strong new patient additions as well as an increase in awareness of real-time CGM.
— The US revenue increased by 34% year-over-year and the international revenue jumped by 52%.
— Revenue from the sensor increased by 42% for the fourth quarter. Transmitter revenue jumped by 46% while receiver revenue plunged by 35%.
— Looking ahead into the full year 2020, the company reaffirmed revenue outlook in the range of $1.725-1.775 billion. This is in line with the consensus view of $1.77 billion.
— The revenue outlook is driven by strong growth in sensor volumes, continued international expansion, shifting channel mix and overall market dynamics.
— The gross margin is still expected to be about 64% and the adjusted operating margin is predicted to be about 13%. The adjusted EBITDA margin outlook is about 23%.
Most Popular
CVX Earnings: Chevron reports lower revenue and profit for Q1 2024
Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or
ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up
Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net
CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results
Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was
